Skip to content

Clinical study to explore the efficacy of a diaper changing products regimen in diaper rash prevention

Pilot, comparative, monocentric clinical study to explore the efficacy of a diaper change regimen, composed by diaper, diaper rash cream and wet wipes, on diaper rash prevention (E005562C)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3w64rhx
Enrollment
Unknown
Registered
2025-02-05
Start date
2024-08-14
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diaper Rash

Interventions

This is a 5-week, open-label, non-randomized, single-arm, comparative pilot clinical trial. Approximately 55 infants aged 6 to 12 months who meet the eligibility criteria will be enrolled. All infants
E07.325.068.249

Sponsors

Kimberly-Clark Brasil Industria e Comercio De Produtos De Higiene Ltda
Lead Sponsor
Kimberly-Clark Brasil Industria e Comercio De Produtos De Higiene Ltda
Collaborator

Eligibility

Age
6 Months to 12 Months

Inclusion criteria

Inclusion criteria: Infants from 6 to 12 months old; both sexes; in good general health; free from diaper rash or presenting a mild to moderate diaper rash; legal guardians are more than 18 years old and have signed the informed consent form

Exclusion criteria

Exclusion criteria: Subjects who present any allergy and sensitivity to products of the same category of the investigational products; present any history and skin condition that may compromise the study results or the subject’s safety; and have used oral and/or topical antibiotics, antifungals, antihistamines and/or corticosteroids in the 2 weeks prior to enrollment visit

Design outcomes

Primary

MeasureTime frame
It is expected to evaluate the diaper rash incidence during the use of the investigational diaper change regimen compared to usual diaper change products of study subjects through diaper rash occurrence during each regimen

Secondary

MeasureTime frame
It is expected to evaluate the presence of diaper rash after each regimen, usual and investigational through clinical evaluation of diaper rash identified during each regimen;It is expected to evaluate the difference on skin parameters (trans epidermal water loss, hydration and pH) before and after use of the investigational regimen through the average values ??of each biophysical measurement

Countries

Brazil

Contacts

Public ContactJéssica Pereira

Kimberly-Clark Brasil Industria e Comercio De Produtos De Higiene Ltda

jessica.pereira@kcc.com+55(12)991610904

Outcome results

None listed

Source: REBEC (via WHO ICTRP)